VIOLIN Logo
Cov19VaxKB Banner
Search: for Help
Home
Introduction
Statistics
Authorized Vaccines
Phase III Vaccines
Phase II Vaccines
Phase I Vaccines
Preclinical Vaccines
Vaccine Safety
Vaccine Design
Literature Search
News
Data Submission
Data Exchange
Data Download
Tutorial
Links
Documentation
Updates
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Apr 01, 2025 To Apr 04, 2025:

SARS-CoV-2 (COVID-19)

  1. Hurley LP, Kurlandsky K, Breslin K, Stein A, Hambidge SJ, Shoup JA, Reifler LM, Daley MF, Lewin B, Goddard K, Henninger ML, Nelson JC, Vazquez-Benitez G, Hanson KE, Fuller CC, Williams JTB. Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023 Human vaccines & immunotherapeutics 21(1):2467548 2025 [PMID: 40179339]
  2. Daungsupawong H, Wiwanitkit V. Comments on predictors of moderate, severe, and critical COVID-19 infection in a largely vaccinated kidney transplant recipient cohort during the Omicron era Clinical transplantation and research 2025 [PMID: 40176405]
  3. Yang OO. The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years Journal of immunology (Baltimore, Md. : 1950) 2025 [PMID: 40180332]
  4. Esefeld M, Handtke S, Kaiser R, Nicolai L, Di Fina L, Rossaro D, Wesche J, Rath J, Wienrich AC, Hoffmann T, Harasser L, Feistritzer C, Loacker L, Lotfi K, Holmström M, Antovic J, Steil L, Volker U, Ulm L, Becker K, Hübner NO, Greinacher A, Thiele T. Platelet activating histone/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndrome Blood advances 2025 [PMID: 40179418]
  5. Han X, Shi KS, Fan Q, Choudhury PP, Hu X, Yabroff KR. Medicaid Expansion and US Mortality Rates During the COVID-19 Pandemic, 2018-2022 American journal of public health :e1-e10 2025 [PMID: 40179345]
  6. Jobe NB, Rose E, Winn AK, Goldstein L, Schneider ZD, Silk BJ. Human Metapneumovirus Seasonality and Co-Circulation with Respiratory Syncytial Virus - United States, 2014-2024 MMWR. Morbidity and mortality weekly report 74(11):182-187 2025 [PMID: 40179043]
  7. Lu HH, Dos Santos Alves RP, Li QH, Eder L, Timis J, Madany H, Chuensirikulchai K, Varghese KV, Singh A, Tran LL, Street A, Elong Ngono A, Croft M, Shresta S. Enhanced durability of a Zika virus self-amplifying RNA vaccine through combinatorial OX40 and 4-1BB agonism JCI insight 2025 [PMID: 40178907]
  8. Muwonge A, Bessell PR, de Clare Bronsvoort MB, Mugerwa I, Mwaka E, Ssebaggala E, Wee BA, Kiayias A, Mpyangu CM, Joloba ML. Assessing the Impact of Haulage Drivers in Uganda's COVID-19 Delta Wave Journal of epidemiology and global health 15(1):54 2025 [PMID: 40178677]
  9. Carroll DR, Conroy SJ, Vamosiu A. The importance of political and religious affiliation in explaining county-level COVID-19 Vaccine Hesitancy Health economics review 15(1):29 2025 [PMID: 40178642]
  10. LeBeau K, Lopez J, Orejuela M, Eliazar-Macke N, Freytes IM. Understanding the intersectionality of the rural Hispanic/Latino Veteran population: a scoping review of health-related challenges Ethnicity & health :1-28 2025 [PMID: 40178346]
  11. Palmer J, Kondapaka M, Beamer BA, Siddiqui T, Sorkin JD, Chen WH, Kheirbek RE. Mortality Trends in Pre-COVID-19 and COVID-19 Eras Among Oldest Veterans The journals of gerontology. Series A, Biological sciences and medical sciences 2025 [PMID: 40177974]
  12. Doraivelu K, Williams S, Hazell M, Smith S, Chamberlain AT, Gandhi NR, Shah NS, Patel SA. The dynamic impact of community social vulnerability on COVID-19 outcomes: A census tract-level analysis of Fulton County, GA Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 [PMID: 40176421]
  13. Bahadir Z, Narayan P, Wolters R, Permar SR, Fouda G, Hessell AJ, Haigwood NL. Monoclonal Antibodies for Pediatric Viral Disease Prevention and Treatment Pediatrics 2025 [PMID: 40174915]
  14. Johnstone SL, Shapiro D, Chiwandire N, Matoti L, Whyte C, Bultinck-Human J, Mametja S, Getz C, Moyo B, Semenya M, Walaza S, Cohen C, Groome MJ. Effectiveness of BNT162b2 and Ad26.COV2.S vaccines against COVID-19-related hospitalisation amongst adult members of a private health insurance plan in South Africa during the Delta and Omicron periods: A test-negative case-control study Vaccine :127068 2025 [PMID: 40180820]
  15. Carter JY, Khamadi S, Mwangi J, Muhula S, Munene SM, Kanyara L, Kinyua J, Lagat N, Chege J, Oira R, Maiyo A, Stewart R, Postma M, Stekelenburg J, Osur J, van Hulst M. Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study BMJ open 15(4):e094546 2025 [PMID: 40180388]
  16. Agustina R, Ekawidyani KR, Mutiyani M, Prafiantini E, Nindya TS, Damayanti W, Rejeki PS, Djuari L, Huriyati E, Bines JE, Juffrie M. Study protocol for a randomised controlled trial evaluating the efficacy of dietary modulation of probiotics on nutritional status and antibody response to SARS-CoV-2 in Indonesian adolescents: gut-lung axis (DIVINE) BMJ open 15(4):e087934 2025 [PMID: 40180370]
  17. Xu Y, Nyberg F, Santosa A, Marking U, Jonsson J, Gisslén M, Wastesson JW, Johnell K. Regional differences in COVID-19 vaccine uptake and their determinants among Swedish older adults Public health 242:324-331 2025 [PMID: 40179817]
  18. Perez Marc G, Coria LM, Ceballos A, Rodriguez JM, Lombardo ME, Bruno L, Páez Córdoba F, Fascetto Cassero CG, Salvatori M, Rios Medrano M, Fulgenzi F, Alzogaray MF, Mykietiuk A, Uriarte IL, Itcovici N, Smith Casabella T, Corral G, Bruno M, Roldán O, Núñez SA, Cahn F, Yerino GA, Bianchi A, Braem V, Christmann A, Corradetti S, Darraidou MC, Di Nunzio L, Estrada T, López Castelo R, Marchionatti C, Pitocco L, Trias Uriarte V, Wood C, Zadoff R, Bues F, Garrido RM, Montomoli E, Manenti A, Demaría A, Prado L, Pueblas Castro C, Saposnik L, Geffner J, Montes de Oca F, Vega JC, Fló J, Bonvehí P, Cassará J, Pasquevich KA, Cassataro J. Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial Vaccine 54:127045 2025 [PMID: 40179522]
  19. Foran AM, Jetten J, Muldoon OT. Religious group membership and conspiracy beliefs influence vaccine uptake: Insights from 20 European countries Vaccine 53:127086 2025 [PMID: 40179437]
  20. Xing J, Niu T, Yu T, Zou B, Shi C, Wang Y, Fan S, Li M, Bao M, Sun Y, Gao K, Qiu J, Zhang D, Wang N, Jiang Y, Huang H, Cao X, Zeng Y, Wang J, Zhang S, Hu J, Zhang D, Sun W, Yang G, Yang W, Wang C. Faecalibacterium prausnitzii-derived outer membrane vesicles reprogram gut microbiota metabolism to alleviate Porcine Epidemic Diarrhea Virus infection Microbiome 13(1):90 2025 [PMID: 40176190]
  21. Berhanu N, Hirpa E, Mohammed H, Legesse A, Deresse G, Assefa E, Tesgera T, Akalu M, Abayneh T, Bayissa B, Tesfaw L, Birhanu K, Gelaye E. Isolation, molecular identification, and phylogenetic analysis of infectious bronchitis virus from commercial chicken farms in Mekele and Bishoftu, Ethiopia, 2023-2024 Virology journal 22(1):90 2025 [PMID: 40176128]
  22. Li M, Song Z, Wan W, Zhou H. Burden of non-COVID-19 lower respiratory infections in China (1990-2021): a global burden of disease study analysis Respiratory research 26(1):125 2025 [PMID: 40176038]
  23. Stuetzle SCW, Willis M, Barnowska EJ, Bonkass AK, Fastenau A. Factors influencing vaccine hesitancy toward non-covid vaccines in South Asia: a systematic review BMC public health 25(1):1246 2025 [PMID: 40175957]
  24. Soltanipur M, Yarmohammadi H, Mahdavi Anari SF, Karimi Nemch M, Taromiha A, Siadat SD. Ramsay-hunt-syndrome associated with unilateral parotitis following COVID-19 vaccine: a case report European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025 [PMID: 40175816]
  25. Chen X, Shi S, Sun H, Zhou L, Wang H, Li Y, Gilson E, Lu Y, Hu L, Ye J. Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals Scientific reports 15(1):11340 2025 [PMID: 40175524]
  26. Zhang H, Chen R, Xu M, Huang X, Zhao W, Zhou J, Zhang M, Xu Y, Shang D, Xie Q, Hao CM. Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination Nephron :1-11 2025 [PMID: 40174580]
  27. Lee R, Kim W-B, Cho S-Y, Nho D, Park C, Chun H-S, Myong J-P, Lee D-G. Genetic relationships of Aspergillus fumigatus in hospital settings during COVID-19 Microbiology spectrum :e0190224 2025 [PMID: 40172201]
  28. Oka M. Papuloerythroderma of Ofuji Associated with Elevated Varicella-zoster Virus Complement-fixing Antibody Titers Following BNT162b2 mRNA COVID-19 Vaccination Acta dermato-venereologica 105:adv42546 2025 [PMID: 40171831]
  29. Fullerton HJ, Hills NK, Wintermark M, Dlamini N, Fox CK, Cummings DD, Bernard TJ, Beslow LA, Sun LR, Grose C, Norris PJ, Di Germanio C. Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment Stroke 2025 [PMID: 40171657]
  30. Arnold CRK, Bharti N, Exten C, Small M, Srinivasan S, Kuchipudi SV, Kapur V, Ferrari MJ. Latent class analysis identifies risk groups to model the expected benefits of SARS-CoV-2 interventions among university students Scientific reports 15(1):11199 2025 [PMID: 40169833]
  31. Kiani B, Sartorius B, Martin BM, Cadavid Restrepo A, Mayfield HJ, Paulino CT, Jarolim P, De St Aubin M, Ramm RS, Dumas D, Garnier S, Etienne MC, Peña F, Abdalla G, Kucharski A, Duke W, Baldwin M, Henríquez B, de la Cruz L, Nilles EJ, Lau CL. Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican Republic Scientific reports 15(1):11203 2025 [PMID: 40169745]
  32. Rudan I, Kerr S, Simpson CR, Kurdi A, Adeloye D, Robertson C, Sheikh A. The COVID-19 pandemic in children and young people during 2022-24: what new did we learn? Journal of global health 15:01002 2025 [PMID: 40168509]
  33. Pereira M. Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025 American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2025 [PMID: 40180183]
  34. Kitano T, Motoki T, Onaka M, Murata M, Onishi M, Mori T, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Suzuki R, Yoshida S. A questionnaire survey for Japanese parents on intention to vaccinate their children against COVID-19 and influenza Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy :102693 2025 [PMID: 40180119]
  35. Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM. A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial The Lancet. Haematology 12(4):e294-e303 2025 [PMID: 40175001]
  36. Mauro FR. Improving SARS-CoV-2 vaccine response is challenging in chronic lymphocytic leukaemia The Lancet. Haematology 12(4):e238-e239 2025 [PMID: 40174993]
  37. Molinos-Albert LM, Rubio R, Martín-Pérez C, Pradenas E, Torres C, Jiménez A, Canyelles M, Vidal M, Barrios D, Marfil S, Aparicio E, Ramírez-Morros A, Trinité B, Vidal-Alaball J, Santamaria P, Serra P, Izquierdo L, Aguilar R, Ruiz-Comellas A, Blanco J, Dobaño C, Moncunill G. Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic Cell reports 44(4):115498 2025 [PMID: 40173043]
  38. Wee LE, Lim JT, Loy EX, Chiew CJ, Tai ES, Lim SC, Bee YM, Tan SH, Chan CQF, Chow WL, Yip JWL, Yeo KK, Ong B, Lye DCB, Chan MYY, Hausenloy DJ, Tan KB. Risk of New-Onset Type 2 Diabetes Among Vaccinated Adults After Omicron or Delta Variant SARS-CoV-2 Infection JAMA network open 8(4):e252959 2025 [PMID: 40172892]
  39. Nielsen BF, Saad-Roy CM, Metcalf CJE, Viboud C, Grenfell BT. Eco-evolutionary dynamics of pathogen immune-escape: deriving a population-level phylodynamic curve Journal of the Royal Society, Interface 22(225):20240675 2025 [PMID: 40172571]
  40. Smith BD, Matungwa DJ, Huang T, Newton M, Cannon P, Williams M, Foster MW. Leveraging the Arts to Address and Elevate Vaccine Confidence: A Culturally Responsive and Equitable Evaluation of an Arts Intervention for Black Residents in Rural Georgia Qualitative health research 35(4-5):539-553 2025 [PMID: 40171588]
  41. Liu Y, Deng S, Ren S, Tam RC, Liu S, Zhang AJ, To KK, Yuen KY, Chen H, Wang P. Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models Nature communications 16(1):3133 2025 [PMID: 40169649]
  42. Carmola LR, Roebling AD, Khosravi D, Langsjoen RM, Bombin A, Bixler B, Reid A, Chen C, Wang E, Lu Y, Zheng Z, Zhang R, Nguyen PV, Arthur RA, Fitts E, Gulick DA, Higginbotham D, Taz A, Ahmed A, Crumpler JH, Kraft C, Lam WA, Babiker A, Waggoner JJ, Openo KP, Johnson LM, Westbrook A, Piantadosi A. Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA PloS one 20(4):e0317972 2025 [PMID: 40168303]
  43. Surie D, Yuengling KA, Safdar B, Ginde AA, Peltan ID, Brown SM, Gaglani M, Ghamande S, Gottlieb RL, Columbus C, Mohr NM, Gibbs KW, Hager DN, O'Rourke M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Busse LW, Felzer J, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Lauring AS, Martin ET, Mosier JM, Harris ES, Baughman A, Swan SA, Johnson CA, Blair PW, Lewis NM, Ellington S, Rutkowski RE, Zhu Y, Self WH, Dawood FS. Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination JAMA network open 8(4):e252841 2025 [PMID: 40168024]
  44. Dabaja-Younis H, Kandel C, Green K, Johnstone J, Zhong Z, Kassee C, Allen V, Armstrong I, Baqi M, Barker K, Bitnun A, Borgia S, Campigotto A, Chakrabarti S, Gold WL, Golden A, Kitai I, Kus J, Macdonald L, Martin I, Muller M, Nadarajah J, Ostrowska K, Ricciuto D, Richardson D, Saffie M, Tadros M, Tyrrell G, Varia M, Almohri H, Barati S, Crowl G, Farooqi L, Lefebvre M, Li AX, Malik N, Pejkovska M, Sultana A, Vikulova T, Hassan K, Plevneshi A, McGeer A. Invasive Group A Streptococcal Infection in Children, 1992-2023 JAMA network open 8(4):e252861 2025 [PMID: 40168022]
  45. Zhang T, Wen W, Coulter KM, Tse HW, Kim SY. Familial Educational Factors and COVID-19 Vaccine Beliefs Among Mexican-Origin Youth Journal of immigrant and minority health 2025 [PMID: 40167869]
  46. Albrich WC, Just N, Kahlert C, Casanova C, Baty F, Hilty M. Serotype epidemiology and case-fatality risk of invasive pneumococcal disease; a nationwide population study from Switzerland, 2012-2022 Emerging microbes & infections :2488189 2025 [PMID: 40167153]
  47. Parums DV. Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans Medical science monitor : international medical journal of experimental and clinical research 31:e949109 2025 [PMID: 40165538]
  48. Koupaei FN, Kiumarsy A, Feizi MM, Vajdi Z, Edalat Pishkar S, Alem M, Roohparvar Basmenj E. Design of a multi-epitope vaccine candidate against Vibrio cholerae Scientific reports 15(1):11033 2025 [PMID: 40164630]
  49. Azevedo NH, Massi L, Lima GS. Thematic trends in fact-checking in Brazil's COVID-19 infodemic: the first year in focus Anais da Academia Brasileira de Ciencias 97(2):e20240316 2025 [PMID: 40172332]
  50. Karan S, Opdensteinen P, Ma Y, De Oliveira JFA, Steinmetz NF. A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles Vaccine 53:127063 2025 [PMID: 40168732]
  51. Hussein NR, Khalid RC, Jamal TB, Mahdi SA, Mustafa AS, Mohammed BI, Shukri MA, Naqid IA, Ameen RM. Prevalence of anti-SARS-CoV-2 IgG positivity and long COVID-19 in pediatric age group Journal of infection in developing countries 19(3):335-341 2025 [PMID: 40168375]
  52. Reinhart AM, Tian Y, Lilly AE. Get Vaccinated Now, But the Choice is Up to You: Framing, Psychological Reactance, and Autonomy Restoration Scripts for COVID-19 Vaccine Hesitancy Health communication :1-12 2025 [PMID: 40165490]
  53. Hubeny TJ, Nahon LS, Ng NL, Gawronski B. Who Falls for Misinformation and Why? Personality & social psychology bulletin :1461672251328800 2025 [PMID: 40165403]
  54. Ackerman A, Nigon B, Wait A, Ali E, Wilkinson-Lee AM, Cohen A, Jones M, Cortez IG, Kelly K, Fabricant R, Serrano-Feliciano J, Stanowski J, Cullen T. Using human-centered design to advance health literacy in local health department programming: a case study BMC public health 25(1):1207 2025 [PMID: 40165172]
  55. Shibli H, Kuodi P, Dror A, Zayyad H, Wertheim O, Jabal KA, Nazzal S, Glikman D, Edelstein M. Changes in long-term employment and income following COVID-19 (SARS-CoV-2) infection among Jewish and Arab populations in Israel BMC public health 25(1):1205 2025 [PMID: 40165167]
  56. Trilla A, Trilla G, Aldea M, Vilella A. What Is Next for COVID-19 Vaccination? Seminars in respiratory and critical care medicine 2025 [PMID: 40164121]
  57. Zhang M, Zhu Y, Li N, Aishanjiang K, Zhu S, Tang A, Li G, Liu G. Development of a monoclonal antibody-based colloidal gold immunochromatographic strip for rapid detection of feline coronavirus International journal of biological macromolecules :142683 2025 [PMID: 40169048]
  58. Pietà AD, Genova B, Penna A, Sinigaglia A, Vogiatzis S, Barzon L, Pagliari M, Bonfante F, Torrigiani F, Sofia T, Verin R, Tosi A, Carpanese D, Sommaggio R, Barbieri V, Santa SD, Zuccolotto G, Grigoletto A, Pasut G, Rosato A. On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine Journal of controlled release : official journal of the Controlled Release Society :113674 2025 [PMID: 40164435]
  59. Ito S, Nishikawa A, Kuroiwa R, Honda K, Nagata S. COVID-19 infection and vaccination in children with Dravet syndrome or infantile epileptic spasms syndrome: An internet survey in Japan Brain & development 47(3):104352 2025 [PMID: 40163980]
  60. Chen S, Creswell R, Hounsell R, Cantrell L, Bajaj S, Dahal P, Tsui Lok Hei J, Kolade O, Amswych M, Naidoo R, Fowler T, Hopkins S, Stepniewska K, Voysey M, White L, Shretta R, Lambert B. Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England BMJ public health 3(1):e001376 2025 [PMID: 40177370]
  61. de-Winton Cummings PJ, Gonzalez Bravo C, Dukes KC, Wilks AD, Ahlers CD, Casado Castillo FE, Courtney A, Elliott-Wherry AN, Knobbe JE, Pineiro-Falcon NM, Schaeffer SE, Tillinghast S, Tovar EF, Villa AT, Carvour ML. Modifiable social and structural factors influence COVID-19 vaccine intention among frontline workers in the Midwestern USA: a community-engaged survey study BMJ public health 3(1):e000859 2025 [PMID: 40166606]
  62. Ash RW, Carpenter-Song E, Sosin AN, Moen EL, Gunn C. The role of place-based consciousness in COVID-19 vaccine hesitancy: A survey analysis across rural and urban subgroups in the U.S Social science & medicine (1982) 373:118019 2025 [PMID: 40179571]
  63. Venkatesh SS, T M, Gowda MAS. A Cross-Sectional Study on Post-COVID-19 Menstrual Abnormalities in Women of Reproductive Age Group at a Tertiary Care Hospital Obstetrics and gynecology international 2025:1771858 2025 [PMID: 40171476]
  64. Yang Q, Zhang M, Dong Z, Deng F. A predictive model to explore risk factors for Henoch-Schönlein purpura nephritis in children: a retrospective cross-sectional study Frontiers in public health 13:1507408 2025 [PMID: 40177080]
  65. Korosec CS, Conway JM, Matveev VA, Ostrowski M, Heffernan JM, Ghaemi MS. Machine Learning Reveals Distinct Immunogenic Signatures of Th1 Imprinting in ART-Treated Individuals with HIV Following Repeated SARS-CoV-2 Vaccination bioRxiv : the preprint server for biology 2025 [PMID: 40166325]
  66. Hawkins M, Robley B, Alem F, Narayanan A, Larson P, Hull J, Hajduk I, Wallach M. Economically Feasible Mass Production of Egg Yolk Powder Tablets (Chicken IgY) for Global COVID-19 Transmission Prevention Research square 2025 [PMID: 40166022]
  67. Murad M, Atkin SL, Wasif P, Behzad AA, Husain AMJA, Leahy R, d'Hellencourt FL, Joury J, Aziz MA, Valluri SR, Haridy H, Spinardi J, Kyaw MH, Al-Qahtani M. Burden of acute and long-term COVID-19: a nationwide study in Bahrain Frontiers in public health 13:1539453 2025 [PMID: 40171435]
  68. Xiao C, Xiang J, Wang H, Gao W, Peng T, Li S, Su J, Chen X, Gao L, Shi R, Mou X, Yuan J, Chen G. Characterizing HLA-A2-restricted CD8(+) T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients Frontiers in immunology 16:1534530 2025 [PMID: 40170856]
  69. Piano Mortari E, Ferrucci F, Zografaki I, Carsetti R, Pacelli L. T and B cell responses in different immunization scenarios for COVID-19: a narrative review Frontiers in immunology 16:1535014 2025 [PMID: 40170841]
  70. Li Y, Viswaroopan D, He W, Li J, Zuo X, Xu H, Tao C. Enhancing Relation Extraction for COVID-19 Vaccine Shot-Adverse Event Associations with Large Language Models Research square 2025 [PMID: 40166033]
  71. González-Domínguez I, Abdeljawad A, Lai TY, Boza M, McCroskery S, Lemus N, Slamanig S, Singh G, Warang P, Yellin T, Abbad A, Carreño JM, Dolange V, Martínez-Guevara JL, Singh G, Barcena-Varela M, Chang LA, Schotsaert M, Krammer F, Palese P, Sun W. Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models Frontiers in immunology 16:1524477 2025 [PMID: 40165947]
  72. Shaholli D. The critical role of vaccinations for Healthcare Workers after COVID-19 La Clinica terapeutica 176(2):158-159 2025 [PMID: 40176583]
  73. Wu Y, Jia X, Wu N, Zhang X, Wu Y, Liu Y, Zhou M, Shen Y, Li E, Wang W, Lan J, Wang Y, Chiu S. Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants Acta pharmaceutica Sinica. B 15(2):947-962 2025 [PMID: 40177579]
  74. Yi D, Zhang Y, Wang J, Liu Q, Ma L, Li Q, Guo S, Zheng R, Li X, Li X, Dong Y, Lu S, Zhang W, Peng X, Cen S. Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates Acta pharmaceutica Sinica. B 15(2):934-946 2025 [PMID: 40177573]
  75. . Erratum: Comparison of the Test-negative Design and Cohort Design With Explicit Target Trial Emulation for Evaluating COVID-19 Vaccine Effectiveness Epidemiology (Cambridge, Mass.) 2025 [PMID: 40173425]
  76. Nag R, Srivastava S, Rizvi S, Ahmed S, Raza ST. Innovations in vaccine design: Computational tools and techniques Advances in pharmacology (San Diego, Calif.) 103:375-391 2025 [PMID: 40175050]
  77. Mergenova G, Davis A, Rosenthal SL, Terlikbayeva A, Primbetova S, Darisheva M, Bukharbayeva A, Denebayeva AY, DeHovitz J. Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus Journal of the International Association of Providers of AIDS Care 24:23259582251328861 2025 [PMID: 40170389]
  78. Ramírez D, Rojas R, Fierro H, Nova DA, Renard GM, Ampuero E, Fuentealba J, Martínez A, Gil C, Reyes-Parada M. Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients Revista medica de Chile 152(12):1198-1208 2024 [PMID: 40178212]
  79. Fukuzawa N, Matsuo K, Atsumi G, Tasaka Y, Mitsuda N. Plant-made pharmaceuticals Plant biotechnology (Tokyo, Japan) 41(3):243-260 2024 [PMID: 40177139]

See more by clicking HERE

Coronavirus

  1. Hurley LP, Kurlandsky K, Breslin K, Stein A, Hambidge SJ, Shoup JA, Reifler LM, Daley MF, Lewin B, Goddard K, Henninger ML, Nelson JC, Vazquez-Benitez G, Hanson KE, Fuller CC, Williams JTB. Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023 Human vaccines & immunotherapeutics 21(1):2467548 2025 [PMID: 40179339]
  2. Muwonge A, Bessell PR, de Clare Bronsvoort MB, Mugerwa I, Mwaka E, Ssebaggala E, Wee BA, Kiayias A, Mpyangu CM, Joloba ML. Assessing the Impact of Haulage Drivers in Uganda's COVID-19 Delta Wave Journal of epidemiology and global health 15(1):54 2025 [PMID: 40178677]
  3. Carter JY, Khamadi S, Mwangi J, Muhula S, Munene SM, Kanyara L, Kinyua J, Lagat N, Chege J, Oira R, Maiyo A, Stewart R, Postma M, Stekelenburg J, Osur J, van Hulst M. Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study BMJ open 15(4):e094546 2025 [PMID: 40180388]
  4. Agustina R, Ekawidyani KR, Mutiyani M, Prafiantini E, Nindya TS, Damayanti W, Rejeki PS, Djuari L, Huriyati E, Bines JE, Juffrie M. Study protocol for a randomised controlled trial evaluating the efficacy of dietary modulation of probiotics on nutritional status and antibody response to SARS-CoV-2 in Indonesian adolescents: gut-lung axis (DIVINE) BMJ open 15(4):e087934 2025 [PMID: 40180370]
  5. Xing J, Niu T, Yu T, Zou B, Shi C, Wang Y, Fan S, Li M, Bao M, Sun Y, Gao K, Qiu J, Zhang D, Wang N, Jiang Y, Huang H, Cao X, Zeng Y, Wang J, Zhang S, Hu J, Zhang D, Sun W, Yang G, Yang W, Wang C. Faecalibacterium prausnitzii-derived outer membrane vesicles reprogram gut microbiota metabolism to alleviate Porcine Epidemic Diarrhea Virus infection Microbiome 13(1):90 2025 [PMID: 40176190]
  6. Berhanu N, Hirpa E, Mohammed H, Legesse A, Deresse G, Assefa E, Tesgera T, Akalu M, Abayneh T, Bayissa B, Tesfaw L, Birhanu K, Gelaye E. Isolation, molecular identification, and phylogenetic analysis of infectious bronchitis virus from commercial chicken farms in Mekele and Bishoftu, Ethiopia, 2023-2024 Virology journal 22(1):90 2025 [PMID: 40176128]
  7. Li M, Song Z, Wan W, Zhou H. Burden of non-COVID-19 lower respiratory infections in China (1990-2021): a global burden of disease study analysis Respiratory research 26(1):125 2025 [PMID: 40176038]
  8. Chen X, Shi S, Sun H, Zhou L, Wang H, Li Y, Gilson E, Lu Y, Hu L, Ye J. Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals Scientific reports 15(1):11340 2025 [PMID: 40175524]
  9. Zhang H, Chen R, Xu M, Huang X, Zhao W, Zhou J, Zhang M, Xu Y, Shang D, Xie Q, Hao CM. Relapse Risk in Patients with Membranous Nephropathy after Inactivated COVID-19 Vaccination Nephron :1-11 2025 [PMID: 40174580]
  10. Arnold CRK, Bharti N, Exten C, Small M, Srinivasan S, Kuchipudi SV, Kapur V, Ferrari MJ. Latent class analysis identifies risk groups to model the expected benefits of SARS-CoV-2 interventions among university students Scientific reports 15(1):11199 2025 [PMID: 40169833]
  11. Kiani B, Sartorius B, Martin BM, Cadavid Restrepo A, Mayfield HJ, Paulino CT, Jarolim P, De St Aubin M, Ramm RS, Dumas D, Garnier S, Etienne MC, Peña F, Abdalla G, Kucharski A, Duke W, Baldwin M, Henríquez B, de la Cruz L, Nilles EJ, Lau CL. Spatial multilevel analysis of individual, household, and community factors associated with COVID-19 vaccine hesitancy in the Dominican Republic Scientific reports 15(1):11203 2025 [PMID: 40169745]
  12. Rudan I, Kerr S, Simpson CR, Kurdi A, Adeloye D, Robertson C, Sheikh A. The COVID-19 pandemic in children and young people during 2022-24: what new did we learn? Journal of global health 15:01002 2025 [PMID: 40168509]
  13. Kitano T, Motoki T, Onaka M, Murata M, Onishi M, Mori T, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Suzuki R, Yoshida S. A questionnaire survey for Japanese parents on intention to vaccinate their children against COVID-19 and influenza Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy :102693 2025 [PMID: 40180119]
  14. Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM. A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial The Lancet. Haematology 12(4):e294-e303 2025 [PMID: 40175001]
  15. Molinos-Albert LM, Rubio R, Martín-Pérez C, Pradenas E, Torres C, Jiménez A, Canyelles M, Vidal M, Barrios D, Marfil S, Aparicio E, Ramírez-Morros A, Trinité B, Vidal-Alaball J, Santamaria P, Serra P, Izquierdo L, Aguilar R, Ruiz-Comellas A, Blanco J, Dobaño C, Moncunill G. Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic Cell reports 44(4):115498 2025 [PMID: 40173043]
  16. Nielsen BF, Saad-Roy CM, Metcalf CJE, Viboud C, Grenfell BT. Eco-evolutionary dynamics of pathogen immune-escape: deriving a population-level phylodynamic curve Journal of the Royal Society, Interface 22(225):20240675 2025 [PMID: 40172571]
  17. Smith BD, Matungwa DJ, Huang T, Newton M, Cannon P, Williams M, Foster MW. Leveraging the Arts to Address and Elevate Vaccine Confidence: A Culturally Responsive and Equitable Evaluation of an Arts Intervention for Black Residents in Rural Georgia Qualitative health research 35(4-5):539-553 2025 [PMID: 40171588]
  18. Carmola LR, Roebling AD, Khosravi D, Langsjoen RM, Bombin A, Bixler B, Reid A, Chen C, Wang E, Lu Y, Zheng Z, Zhang R, Nguyen PV, Arthur RA, Fitts E, Gulick DA, Higginbotham D, Taz A, Ahmed A, Crumpler JH, Kraft C, Lam WA, Babiker A, Waggoner JJ, Openo KP, Johnson LM, Westbrook A, Piantadosi A. Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA PloS one 20(4):e0317972 2025 [PMID: 40168303]
  19. Surie D, Yuengling KA, Safdar B, Ginde AA, Peltan ID, Brown SM, Gaglani M, Ghamande S, Gottlieb RL, Columbus C, Mohr NM, Gibbs KW, Hager DN, O'Rourke M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Busse LW, Felzer J, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Lauring AS, Martin ET, Mosier JM, Harris ES, Baughman A, Swan SA, Johnson CA, Blair PW, Lewis NM, Ellington S, Rutkowski RE, Zhu Y, Self WH, Dawood FS. Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination JAMA network open 8(4):e252841 2025 [PMID: 40168024]
  20. Azevedo NH, Massi L, Lima GS. Thematic trends in fact-checking in Brazil's COVID-19 infodemic: the first year in focus Anais da Academia Brasileira de Ciencias 97(2):e20240316 2025 [PMID: 40172332]
  21. Hussein NR, Khalid RC, Jamal TB, Mahdi SA, Mustafa AS, Mohammed BI, Shukri MA, Naqid IA, Ameen RM. Prevalence of anti-SARS-CoV-2 IgG positivity and long COVID-19 in pediatric age group Journal of infection in developing countries 19(3):335-341 2025 [PMID: 40168375]
  22. Ackerman A, Nigon B, Wait A, Ali E, Wilkinson-Lee AM, Cohen A, Jones M, Cortez IG, Kelly K, Fabricant R, Serrano-Feliciano J, Stanowski J, Cullen T. Using human-centered design to advance health literacy in local health department programming: a case study BMC public health 25(1):1207 2025 [PMID: 40165172]
  23. Shibli H, Kuodi P, Dror A, Zayyad H, Wertheim O, Jabal KA, Nazzal S, Glikman D, Edelstein M. Changes in long-term employment and income following COVID-19 (SARS-CoV-2) infection among Jewish and Arab populations in Israel BMC public health 25(1):1205 2025 [PMID: 40165167]
  24. Zhang M, Zhu Y, Li N, Aishanjiang K, Zhu S, Tang A, Li G, Liu G. Development of a monoclonal antibody-based colloidal gold immunochromatographic strip for rapid detection of feline coronavirus International journal of biological macromolecules :142683 2025 [PMID: 40169048]
  25. Ito S, Nishikawa A, Kuroiwa R, Honda K, Nagata S. COVID-19 infection and vaccination in children with Dravet syndrome or infantile epileptic spasms syndrome: An internet survey in Japan Brain & development 47(3):104352 2025 [PMID: 40163980]
  26. Murad M, Atkin SL, Wasif P, Behzad AA, Husain AMJA, Leahy R, d'Hellencourt FL, Joury J, Aziz MA, Valluri SR, Haridy H, Spinardi J, Kyaw MH, Al-Qahtani M. Burden of acute and long-term COVID-19: a nationwide study in Bahrain Frontiers in public health 13:1539453 2025 [PMID: 40171435]
  27. Xiao C, Xiang J, Wang H, Gao W, Peng T, Li S, Su J, Chen X, Gao L, Shi R, Mou X, Yuan J, Chen G. Characterizing HLA-A2-restricted CD8(+) T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients Frontiers in immunology 16:1534530 2025 [PMID: 40170856]
  28. Piano Mortari E, Ferrucci F, Zografaki I, Carsetti R, Pacelli L. T and B cell responses in different immunization scenarios for COVID-19: a narrative review Frontiers in immunology 16:1535014 2025 [PMID: 40170841]
  29. González-Domínguez I, Abdeljawad A, Lai TY, Boza M, McCroskery S, Lemus N, Slamanig S, Singh G, Warang P, Yellin T, Abbad A, Carreño JM, Dolange V, Martínez-Guevara JL, Singh G, Barcena-Varela M, Chang LA, Schotsaert M, Krammer F, Palese P, Sun W. Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models Frontiers in immunology 16:1524477 2025 [PMID: 40165947]
  30. Yi D, Zhang Y, Wang J, Liu Q, Ma L, Li Q, Guo S, Zheng R, Li X, Li X, Dong Y, Lu S, Zhang W, Peng X, Cen S. Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates Acta pharmaceutica Sinica. B 15(2):934-946 2025 [PMID: 40177573]
  31. Mergenova G, Davis A, Rosenthal SL, Terlikbayeva A, Primbetova S, Darisheva M, Bukharbayeva A, Denebayeva AY, DeHovitz J. Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus Journal of the International Association of Providers of AIDS Care 24:23259582251328861 2025 [PMID: 40170389]
  32. Ramírez D, Rojas R, Fierro H, Nova DA, Renard GM, Ampuero E, Fuentealba J, Martínez A, Gil C, Reyes-Parada M. Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients Revista medica de Chile 152(12):1198-1208 2024 [PMID: 40178212]

See more by clicking HERE

Click HERE to see the publications in the last month.